330 related articles for article (PubMed ID: 30929316)
1. Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence.
Khemais-Benkhiat S; Belcastro E; Idris-Khodja N; Park SH; Amoura L; Abbas M; Auger C; Kessler L; Mayoux E; Toti F; Schini-Kerth VB
J Cell Mol Med; 2020 Feb; 24(3):2109-2122. PubMed ID: 30929316
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins.
Park SH; Belcastro E; Hasan H; Matsushita K; Marchandot B; Abbas M; Toti F; Auger C; Jesel L; Ohlmann P; Morel O; Schini-Kerth VB
Cardiovasc Diabetol; 2021 Mar; 20(1):65. PubMed ID: 33726768
[TBL] [Abstract][Full Text] [Related]
3. Ageing enhances the shedding of splenocyte microvesicles with endothelial pro-senescent effect that is prevented by a short-term intake of omega-3 PUFA EPA:DHA 6:1.
Qureshi AW; Altamimy R; El Habhab A; El Itawi H; Farooq MA; Zobairi F; Hasan H; Amoura L; Kassem M; Auger C; Schini-Kerth V; Toti F
Biochem Pharmacol; 2020 Mar; 173():113734. PubMed ID: 31811867
[TBL] [Abstract][Full Text] [Related]
4. Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
Park SH; Farooq MA; Gaertner S; Bruckert C; Qureshi AW; Lee HH; Benrahla D; Pollet B; Stephan D; Ohlmann P; Lessinger JM; Mayoux E; Auger C; Morel O; Schini-Kerth VB
Cardiovasc Diabetol; 2020 Feb; 19(1):19. PubMed ID: 32070346
[TBL] [Abstract][Full Text] [Related]
5. Fine air pollution particles induce endothelial senescence via redox-sensitive activation of local angiotensin system.
Sharma K; Lee HH; Gong DS; Park SH; Yi E; Schini-Kerth V; Oak MH
Environ Pollut; 2019 Sep; 252(Pt A):317-329. PubMed ID: 31158660
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells.
Uthman L; Homayr A; Juni RP; Spin EL; Kerindongo R; Boomsma M; Hollmann MW; Preckel B; Koolwijk P; van Hinsbergh VWM; Zuurbier CJ; Albrecht M; Weber NC
Cell Physiol Biochem; 2019; 53(5):865-886. PubMed ID: 31724838
[TBL] [Abstract][Full Text] [Related]
7. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
[TBL] [Abstract][Full Text] [Related]
8. The Redox-sensitive Induction of the Local Angiotensin System Promotes Both Premature and Replicative Endothelial Senescence: Preventive Effect of a Standardized Crataegus Extract.
Khemais-Benkhiat S; Idris-Khodja N; Ribeiro TP; Silva GC; Abbas M; Kheloufi M; Lee JO; Toti F; Auger C; Schini-Kerth VB
J Gerontol A Biol Sci Med Sci; 2016 Dec; 71(12):1581-1590. PubMed ID: 26672612
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endothelial SGLT1 and 2.
Bruckert C; Matsushita K; Mroueh A; Amissi S; Auger C; Houngue U; Remila L; Chaker AB; Park SH; Algara-Suarez P; Belcastro E; Jesel L; Ohlmann P; Morel O; Schini-Kerth VB
Vascul Pharmacol; 2022 Oct; 146():107095. PubMed ID: 35944842
[TBL] [Abstract][Full Text] [Related]
10. The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.
Oelze M; Kröller-Schön S; Welschof P; Jansen T; Hausding M; Mikhed Y; Stamm P; Mader M; Zinßius E; Agdauletova S; Gottschlich A; Steven S; Schulz E; Bottari SP; Mayoux E; Münzel T; Daiber A
PLoS One; 2014; 9(11):e112394. PubMed ID: 25402275
[TBL] [Abstract][Full Text] [Related]
11. Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes.
Madonna R; Doria V; Minnucci I; Pucci A; Pierdomenico DS; De Caterina R
J Cell Mol Med; 2020 Nov; 24(21):12331-12340. PubMed ID: 32940423
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium.
Cappetta D; De Angelis A; Ciuffreda LP; Coppini R; Cozzolino A; Miccichè A; Dell'Aversana C; D'Amario D; Cianflone E; Scavone C; Santini L; Palandri C; Naviglio S; Crea F; Rota M; Altucci L; Rossi F; Capuano A; Urbanek K; Berrino L
Pharmacol Res; 2020 Jul; 157():104781. PubMed ID: 32360273
[TBL] [Abstract][Full Text] [Related]
13. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.
Steven S; Oelze M; Hanf A; Kröller-Schön S; Kashani F; Roohani S; Welschof P; Kopp M; Gödtel-Armbrust U; Xia N; Li H; Schulz E; Lackner KJ; Wojnowski L; Bottari SP; Wenzel P; Mayoux E; Münzel T; Daiber A
Redox Biol; 2017 Oct; 13():370-385. PubMed ID: 28667906
[TBL] [Abstract][Full Text] [Related]
14. Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage.
Reyes-Pardo H; Bautista R; Vargas-Robles H; Rios A; Sánchez D; Escalante B
BMC Nephrol; 2019 Aug; 20(1):292. PubMed ID: 31375080
[TBL] [Abstract][Full Text] [Related]
15. Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO).
Li CY; Wang LX; Dong SS; Hong Y; Zhou XH; Zheng WW; Zheng C
Med Sci Monit Basic Res; 2018 Jan; 24():1-9. PubMed ID: 29307883
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways.
Abbas M; Jesel L; Auger C; Amoura L; Messas N; Manin G; Rumig C; León-González AJ; Ribeiro TP; Silva GC; Abou-Merhi R; Hamade E; Hecker M; Georg Y; Chakfe N; Ohlmann P; Schini-Kerth VB; Toti F; Morel O
Circulation; 2017 Jan; 135(3):280-296. PubMed ID: 27821539
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress.
El-Daly M; Pulakazhi Venu VK; Saifeddine M; Mihara K; Kang S; Fedak PWM; Alston LA; Hirota SA; Ding H; Triggle CR; Hollenberg MD
Vascul Pharmacol; 2018 Oct; 109():56-71. PubMed ID: 29908295
[TBL] [Abstract][Full Text] [Related]
18. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
[TBL] [Abstract][Full Text] [Related]
19. Replicative senescence promotes prothrombotic responses in endothelial cells: Role of NADPH oxidase- and cyclooxygenase-derived oxidative stress.
Silva GC; Abbas M; Khemais-Benkhiat S; Burban M; Ribeiro TP; Toti F; Idris-Khodja N; Côrtes SF; Schini-Kerth VB
Exp Gerontol; 2017 Jul; 93():7-15. PubMed ID: 28412252
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway.
Mroueh A; Fakih W; Carmona A; Trimaille A; Matsushita K; Marchandot B; Qureshi AW; Gong DS; Auger C; Sattler L; Reydel A; Hess S; Oulehri W; Vollmer O; Lessinger JM; Meyer N; Pieper MP; Jesel L; Bäck M; Schini-Kerth V; Morel O
J Thromb Haemost; 2024 Jan; 22(1):286-299. PubMed ID: 37797691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
